Balance Sheet China Life Insurance Company Limited

Stocks

2628

CNE1000002L3

Life & Health Insurance

Market Closed - Hong Kong S.E. Other stock markets 04:08:21 2026-06-12 EDT			5-day change	1st Jan Change
30.12 ^HKD	+6.58%		+7.57%	+10.01%

06-05	Top Chinese Insurers Start Buying Dimsum Bonds Through Bond Connect	MT
05-31	Shanghai VAST Technology Co., Ltd. announced that it has received $200 million in funding from China Life Insurance Company Limited, Eminence Venture, INCE Management Consulting Co., Ltd., Genesis Capital Equity S.R.O., Primavera Venture Capital	CI

a1956.RDf-XkbkBhAtxwFNty7an1A-ok67YY1F8JNQl9LpJ3g.C36YKR7WTVJssm4d2H2-2D0T4D-WBcJokdUIpOO6bAIXdYYMKo00KEi3OQ

Published financial data: CHINA LIFE INSURANCE COMPANY LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Premiums and Annuity Revenues	570B	571B	583B	203B	208B
Total Interest And Dividend Income	116B	214B	117B	-30.02B	62.19B
Gain (Loss) on Sale of Investments, Total (Rev)	88.95B	-31.58B	14.76B	118B	63.17B
Other Revenues, Total	19.97B	12.6B	19.61B	22.92B	18.13B
Total Revenues	795B	766B	735B	314B	352B
Policy Benefits	604B	616B	586B	175B	143B
Policy Acquisition / Underwriting Costs, Total	65.74B	54.78B	63.09B	1.8B	1.79B
Selling General & Admin Expenses, Total	42.06B	41.19B	40.35B	7.38B	8.11B
Provision for Bad Debts	-	-	-	-	-
Provision For Loan Losses - (Ins. / REIT / Utility Templates)	-1.38B	1.48B	1.51B	-	-
Other Operating Expenses	13.81B	31.65B	16.68B	8.74B	8.76B
Total Operating Expenses	727B	742B	705B	193B	162B
Operating Income	68.01B	24.19B	29.8B	121B	190B
Interest Expense, Total	-17.83B	-	-17.32B	-4.2B	-4.16B
Currency Exchange Gains (Loss)	645M	-69M	-381M	-25M	-340M
Other Non Operating Income (Expenses)	87M	61M	71M	-82M	-17M
EBT, Excl. Unusual Items	50.91B	24.18B	12.17B	117B	185B
Gain (Loss) on Sale of Assets	69M	122M	73M	88M	57M
Asset Writedown	-88M	-36M	-71M	-1.61B	-3.28B
Other Unusual Items	-398M	-221M	-290M	-387M	-373M
EBT, Incl. Unusual Items	50.5B	24.05B	11.88B	115B	182B
Income Tax Expense	-1.92B	-9.47B	-10.76B	6.27B	25.08B
Earnings From Continuing Operations	52.41B	33.51B	22.63B	109B	157B
Net Income to Company	52.41B	33.51B	22.63B	109B	157B
Minority Interest	-1.49B	-1.43B	-1.52B	-2B	-2.47B
Net Income - (IS)	50.92B	32.08B	21.11B	107B	154B
Preferred Dividend and Other Adjustments	-	-	-	-	-
Net Income to Common Incl Extra Items	50.92B	32.08B	21.11B	107B	154B
Net Income to Common Excl. Extra Items	50.92B	32.08B	21.11B	107B	154B
Per Share Items
Net EPS - Basic	1.8	1.14	0.75	3.78	5.45
Basic EPS - Continuing Operations	1.8	1.14	0.75	3.78	5.45
Basic Weighted Average Shares Outstanding	28.26B	28.26B	28.26B	28.26B	28.26B
Net EPS - Diluted	1.8	1.14	0.75	3.78	5.45
Diluted EPS - Continuing Operations	1.8	1.14	0.75	3.78	5.45
Diluted Weighted Average Shares Outstanding	28.26B	28.26B	28.26B	28.26B	28.26B
Normalized Basic EPS	1.07	0.48	0.22	2.52	4.01
Normalized Diluted EPS	1.07	0.48	0.22	2.52	4.01
Dividend Per Share	0.65	0.49	0.43	0.65	0.86
Payout Ratio	52.35	82.25	105.11	25.17	17.27
American Depositary Receipts Ratio (ADR)	0.5	0.5	0.5	0.5	0.5
Supplemental Items
EBITDA	71.5B	27.98B	33.62B	126B	194B
EBITA	68.35B	24.55B	30.18B	122B	190B
EBIT	68.01B	24.19B	29.8B	121B	190B
EBITDAR	72.08B	28.89B	34.2B	126B	194B
Effective Tax Rate - (Ratio)	-3.8	-39.37	-90.55	5.44	13.81
Current Domestic Taxes	-	-	-	-	-
Total Current Taxes	4.82B	2.19B	1.24B	1.57B	2.13B
Deferred Domestic Taxes	-	-	-	-	-
Total Deferred Taxes	-6.74B	-11.66B	-12B	4.71B	22.94B
Normalized Net Income	30.33B	13.68B	6.08B	71.2B	113B
Interest on Long-Term Debt	1.6B	1.57B	1.55B	571M	792M
Supplemental Operating Expense Items
Advertising Expense	2.4B	2.47B	2.82B	-	-
Marketing Expenses	511M	420M	-	-	-
Selling and Marketing Expenses	2.92B	2.89B	2.82B	-	-
General and Administrative Expenses	-	-	36.99B	-	-
Net Rental Expense, Total	585M	910M	584M	555M	561M
Imputed Operating Lease Interest Expense	352M	-	349M	79.95M	65.53M
Imputed Operating Lease Depreciation	233M	-	235M	475M	495M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Investment In Debt Securities	2,327B	2,454B	2,934B	3,656B	4,100B
Investment In Equity and Preferred Securities, Total	894B	1,120B	1,293B	474B	626B
Trading Asset Securities, Total	207B	224B	254B	1,908B	2,067B
Real Estate Owned	13.37B	13.19B	12.75B	12.32B	11.7B
Policy Loans	240B	254B	270B	-	-
Total Other Investments	540B	522B	420B	468B	468B
Total investments	4,221B	4,587B	5,184B	6,518B	7,273B
Cash And Equivalents	55.8B	85.64B	103B	81.6B	134B
Reinsurance Recoverable - (IS)	6.63B	7.84B	7.97B	30.74B	30.01B
Other Receivables - (Insurance Template)	523B	427B	422B	22.01B	37.47B
Separate Account Assets	9M	7M	8.42B	-	-
Gross Property Plant And Equipment	80.39B	82.31B	83.53B	86.18B	87.84B
Accumulated Depreciation	-24.24B	-26.42B	-28.75B	-30.96B	-33.4B
Net Property Plant And Equipment	56.15B	55.89B	54.77B	55.22B	54.45B
Other Intangibles, Total	8.41B	8.53B	8.37B	8.26B	8.09B
Restricted Cash	5.08B	43.31B	46.43B	4.92B	9.57B
Other Current Assets, Total	3.87B	4.79B	4.63B	759M	1.94B
Deferred Tax Assets Long-Term (Collected)	121M	22.31B	30.29B	40.03B	34.43B
Deferred Charges Long-Term	822M	525M	473M	441M	418M
Other Long-Term Assets, Total	10.58B	9.78B	17.31B	7.7B	7.98B
Total Assets	4,891B	5,252B	5,888B	6,770B	7,591B
Liabilities
Accrued Expenses, Total	19.33B	19.77B	17.11B	11.28B	14.81B
Insurance And Annuity Liabilities	3,844B	4,339B	4,860B	-	-
Unpaid Claims	83.05B	86.97B	91.05B	64.34B	63.64B
Unearned Premiums	62.76B	63.94B	64.04B	5,789B	6,361B
Reinsurance Payable - (BS)	808M	998M	748M	160M	312M
Current Portion of Long-Term Debt	794M	3.19B	12.72B	9.47B	-
Current Portion of Leases	1.09B	919M	757M	767M	777M
Short-Term Borrowings	241B	149B	217B	152B	332B
Long-Term Debt	51.41B	44.58B	35B	38.42B	35.24B
Long-Term Leases	1.09B	650M	498M	551M	762M
Separate Account Liability	9M	7M	8.42B	-	-
Current Income Taxes Payable	248M	238M	309M	237M	298M
Other Current Liabilities - (Brok / FS / Ins. / REIT Template)	868M	1.27B	1.14B	61.92B	87.66B
Unearned Revenue Non Current	95M	92M	88M	84M	81M
Pension & Other Post Retirement Benefits	1.94B	961M	755M	1.23B	1.46B
Deferred Tax Liability Non-Current	7.48B	272M	1.55B	147M	1.48B
Other Non Current Liabilities	89B	95.37B	108B	119B	83.52B
Total Liabilities	4,404B	4,807B	5,418B	6,248B	6,983B
Common Stock, Total	28.26B	28.26B	28.26B	28.26B	28.26B
Additional Paid In Capital	54.3B	53.55B	53.93B	54.16B	53.86B
Retained Earnings	346B	359B	367B	559B	698B
Comprehensive Income and Other	50.3B	-4.93B	11.39B	-132B	-185B
Total Common Equity	479B	436B	460B	510B	595B
Minority Interest	8.07B	8.95B	9.93B	11.57B	13.19B
Total Equity	487B	445B	470B	521B	608B
Total Liabilities And Equity	4,891B	5,252B	5,888B	6,770B	7,591B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	28.26B	28.26B	28.26B	28.26B	28.26B
ECS Total Common Shares Outstanding	28.26B	28.26B	28.26B	28.26B	28.26B
Book Value / Share	16.93	15.43	16.28	18.03	21.06
Tangible Book Value	470B	428B	452B	501B	587B
Tangible Book Value Per Share	16.63	15.13	15.98	17.74	20.77
Total Debt	295B	198B	266B	201B	369B
Net Debt	240B	113B	163B	119B	235B
Debt Equivalent Oper. Leases	4.68B	7.28B	4.67B	4.44B	4.49B
Minority Interest, Total (Incl. Fin. Div)	8.07B	8.95B	9.93B	11.57B	13.19B
Equity Method Investments, Total	258B	261B	258B	302B	308B
Account Code - Inventory Valuation	3	3	3	3	3
Buildings, Total	58.57B	62.93B	63.46B	65.03B	68.72B
Machinery, Total	9.66B	10.15B	11.31B	12B	12.18B
Full Time Employees	103K	102K	100K	98.69K	97.5K

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	50.92B	32.08B	21.11B	107B	154B
Depreciation, Depletion & Amortization	4.56B	4.57B	4.38B	4.62B	4.47B
Amortization of Goodwill and Intangible Assets - (CF)	339M	360M	383M	405M	420M
Total Depreciation, Depletion & Amortization	4.9B	4.93B	4.76B	5.03B	4.89B
Amortization of Deferred Charges, Total	389M	363M	258M	-	-
(Gain) Loss On Sale of Asset - (CF)	1.32B	-1.6B	-66M	-84M	-52M
(Gain) Loss on Sale of Investments - (CF)	26.84B	32.05B	48.89B	-119B	-62.51B
Total Asset Writedown	88M	36M	71M	1.61B	1.2B
Provision and Write-off of Bad Debts	-	-	-	-207M	-
Change in Trading Asset Securities	-44.53B	-35.29B	-13.78B	-	-
Change in Accounts Receivable	3.6B	10.47B	3.54B	24M	-599M
Change In Deferred Taxes	-6.74B	-11.66B	-12B	4.71B	22.94B
Change in insurance Reserves / Liabilities	-	-	-	580B	645B
Change in Other Net Operating Assets (Collected)	22.03B	67.46B	102B	-15.98B	13.69B
Other Operating Activities	228B	253B	233B	-184B	-318B
Cash from Operations	286B	352B	388B	379B	460B
Capital Expenditure	-5.48B	-3.08B	-4.17B	-3.98B	-3.06B
Sale of Property, Plant, and Equipment	341M	363M	1.05B	261M	290M
Cash Acquisitions	-35.92B	-34.74B	-34.04B	-13.72B	-14.16B
Divestitures	559M	4.4B	-	8.66B	57.42B
Investment in Marketable and Equity Securities, Total	-492B	-301B	-566B	-536B	-784B
Net (Increase) Decrease in Loans Originated / Sold - Investing	-35.48B	-18.2B	-16.08B	-	-
Other Investing Activities, Total	174B	188B	191B	190B	196B
Cash from Investing	-394B	-165B	-428B	-355B	-547B
Short Term Debt Issued, Total	117B	-	67.13B	-	-
Long-Term Debt Issued, Total	-	688M	43M	35.06B	56M
Total Debt Issued	117B	688M	67.17B	35.06B	56M
Short Term Debt Repaid, Total	-	-	-	-65.88B	-
Long-Term Debt Repaid, Total	-1.52B	-100B	-1.73B	-36.21B	-13.86B
Total Debt Repaid	-1.52B	-100B	-1.73B	-102B	-13.86B
Repurchase of Common Stock	-	-	-	-	-
Common Dividends Paid	-26.66B	-26.39B	-22.19B	-26.92B	-26.6B
Common & Preferred Stock Dividends Paid	-26.66B	-26.39B	-22.19B	-26.92B	-26.6B
Other Financing Activities, Total	22.1B	5.9B	17.02B	7.18B	185B
Cash from Financing	111B	-120B	60.27B	-86.76B	144B
Foreign Exchange Rate Adjustments	-71M	217M	64M	28M	-30M
Net Change in Cash	3.78B	67.14B	20.47B	-62.56B	56.87B
Supplemental Items
Cash Interest Paid	12.71B	13.34B	-	-	-
Cash Income Tax Paid (Refund)	12.07B	6.22B	5.78B	6.52B	12.87B
Net Debt Issued / Repaid	116B	-99.6B	65.45B	-67.02B	-13.8B
Levered Free Cash Flow	-9.5B	-65.77B	-4.98B	-755B	518B
Unlevered Free Cash Flow	1.65B	-65.77B	5.85B	-753B	521B
Change In Net Working Capital	40.67B	83.1B	13.62B	830B	-400B

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	0.93	0.3	0.33	1.22	1.65
Return on Total Capital	5.99	2.12	2.7	11.45	13.96
Return On Equity %	11.11	7.19	4.95	25.37	27.72
Return on Common Equity	10.97	7.01	4.71	25.54	27.89
Margin Analysis
Gross Profit Margin %	15.56	12.64	11.79	43.74	58.71
SG&A Margin	5.26	5.35	5.46	2.35	2.3
EBITDA Margin %	9	3.65	4.57	39.93	55.08
EBITA Margin %	8.6	3.21	4.11	38.75	54.04
EBIT Margin %	8.56	3.16	4.06	38.62	53.92
Income From Continuing Operations Margin %	6.6	4.38	3.08	34.65	44.49
Net Income Margin %	6.41	4.19	2.87	34.01	43.79
Net Avail. For Common Margin %	6.41	4.19	2.87	34.01	43.79
Normalized Net Income Margin	3.82	1.79	0.83	22.64	32.2
Levered Free Cash Flow Margin	-1.19	-8.59	-0.68	-240.26	147.25
Unlevered Free Cash Flow Margin	0.21	-8.59	0.8	-239.43	147.99
Asset Turnover
Asset Turnover	0.17	0.15	0.13	0.05	0.05
Fixed Assets Turnover	14.32	13.52	13.28	5.72	6.42
Receivables Turnover (Average Receivables)	33.38	39.19	33.99	-	-
Short Term Liquidity
Current Ratio	0.58	0.88	0.82	0.34	0.34
Quick Ratio	0.48	0.69	0.66	0.33	0.33
Operating Cash Flow to Current Liabilities	0.44	0.65	0.62	0.06	0.07
Days Sales Outstanding (Average Receivables)	10.94	9.31	10.74	-	-
Average Days Payable Outstanding	168.6	169.2	172.38	131.17	161.37
Long Term Solvency
Total Debt/Equity	60.68	44.55	56.52	38.53	60.59
Total Debt / Total Capital	37.76	30.82	36.11	27.81	37.73
LT Debt/Equity	10.79	10.16	7.55	7.48	5.92
Long-Term Debt / Total Capital	6.71	7.03	4.82	5.4	3.69
Total Liabilities / Total Assets	90.05	91.52	92.02	92.3	91.99
EBIT / Interest Expense	3.81	-	1.72	28.91	45.63
EBITDA / Interest Expense	4.09	-	1.99	30.11	46.81
(EBITDA - Capex) / Interest Expense	3.78	-	1.75	29.16	46.07
Total Debt / EBITDA	4.05	6.81	7.69	1.59	1.89
Net Debt / EBITDA	3.28	3.87	4.7	0.94	1.21
Total Debt / (EBITDA - Capex)	4.38	7.61	8.74	1.64	1.92
Net Debt / (EBITDA - Capex)	3.55	4.33	5.35	0.97	1.23
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	2.03	-3.63	-4.05	43.33	11.91
Gross Profit, 1 Yr. Growth %	4.14	-21.71	-10.54	87.81	50.2
EBITDA, 1 Yr. Growth %	0.79	-47.75	-26.25	117.43	53.26
EBITA, 1 Yr. Growth %	0.47	-51.26	-28.4	131.05	56.6
EBIT, 1 Yr. Growth %	0.45	-51.64	-28.7	130.29	56.25
Earnings From Cont. Operations, 1 Yr. Growth %	2.02	-35.87	-32.47	106.69	43.7
Net Income, 1 Yr. Growth %	1.32	-36.8	-34.2	108.92	44.09
Normalized Net Income, 1 Yr. Growth %	-8.6	-54.74	-55.56	128.23	59.12
Diluted EPS Before Extra, 1 Yr. Growth %	1.69	-36.8	-34.2	108.84	44.18
Net Property, Plant and Equip., 1 Yr. Growth %	2.38	-2.62	-1.99	0.82	-1.4
Accounts Receivable, 1 Yr. Growth %	-1.78	-3.26	9.26	-	-
Total Assets, 1 Yr. Growth %	15.02	7.35	12.12	19.74	12.13
Common Equity, 1 Yr. Growth %	6.34	-8.95	5.49	55.49	16.78
Tangible Book Value, 1 Yr. Growth %	6.44	-9.12	5.64	56.98	17.09
Cash From Operations, 1 Yr. Growth %	-5.78	22.87	10.3	-1.45	21.42
Capital Expenditures, 1 Yr. Growth %	-26.7	-44.9	35.6	-4.6	-23.2
Levered Free Cash Flow, 1 Yr. Growth %	-135.57	394.6	-92.43	-115.55	-168.45
Unlevered Free Cash Flow, 1 Yr. Growth %	-95.27	394.6	-110.67	-115.5	-169.03
Dividend Per Share, 1 Yr. Growth %	1.56	-24.62	-12.24	51.16	31.69
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	7.38	-0.84	-3.84	15.28	26.65
Gross Profit, 2 Yr. CAGR %	-0.05	-9.7	-16.31	11.94	67.96
EBITDA, 2 Yr. CAGR %	-4.68	-37.2	-20.77	14.65	83.2
EBITA, 2 Yr. CAGR %	-5.26	-39.93	-22.59	15.24	89.9
EBIT, 2 Yr. CAGR %	-5.3	-40.23	-22.82	15.05	89.69
Earnings From Cont. Operations, 2 Yr. CAGR %	-5.76	-19.23	-34.19	26.47	72.34
Net Income, 2 Yr. CAGR %	-6.53	-20.1	-35.52	26.64	73.5
Normalized Net Income, 2 Yr. CAGR %	-9.28	-35.79	-55.15	13.11	90.57
Diluted EPS Before Extra, 2 Yr. CAGR %	-6.26	-19.92	-35.52	26.56	73.52
Net Property, Plant and Equip., 2 Yr. CAGR %	1.75	0.94	-2.3	-0.6	-0.3
Accounts Receivable, 2 Yr. CAGR %	8.55	-2.52	2.81	-	-
Total Assets, 2 Yr. CAGR %	14.56	11.13	9.71	16.24	15.87
Common Equity, 2 Yr. CAGR %	8.87	-1.55	-2	18	34.75
Tangible Book Value, 2 Yr. CAGR %	9.01	-1.61	-2.02	18.43	35.58
Cash From Operations, 2 Yr. CAGR %	0.07	7.6	16.42	4.74	9.39
Capital Expenditures, 2 Yr. CAGR %	-30.74	-35.83	-13.57	13.73	-14.4
Levered Free Cash Flow, 2 Yr. CAGR %	-68.39	56.96	-38.79	220.23	-67.34
Unlevered Free Cash Flow, 2 Yr. CAGR %	-87.46	37.4	-33.7	219.67	-67.26
Dividend Per Share, 2 Yr. CAGR %	-5.64	-12.5	-18.66	15.18	41.09
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	15.27	3.58	-1.92	-26.59	14.14
Gross Profit, 3 Yr. CAGR %	19.11	-7.87	-9.98	3.61	23.47
EBITDA, 3 Yr. CAGR %	30.25	-29.15	-22.04	32.85	26.59
EBITA, 3 Yr. CAGR %	31.23	-31.43	-23.73	34.24	27.5
EBIT, 3 Yr. CAGR %	31.4	-31.68	-23.93	34.39	27.41
Earnings From Cont. Operations, 3 Yr. CAGR %	63.75	-17.19	-23.91	27.75	31.97
Net Income, 3 Yr. CAGR %	64.71	-18.05	-25.11	28.19	32.21
Normalized Net Income, 3 Yr. CAGR %	53.72	-28.12	-43.2	33.04	26.74
Diluted EPS Before Extra, 3 Yr. CAGR %	66.56	-17.86	-25	28.15	32.18
Net Property, Plant and Equip., 3 Yr. CAGR %	6.52	1	-0.04	-1.27	-0.87
Accounts Receivable, 3 Yr. CAGR %	9.17	4.46	1.26	-	-
Total Assets, 3 Yr. CAGR %	14.55	12.12	11.46	11.43	14.86
Common Equity, 3 Yr. CAGR %	14.55	2.61	0.74	2.09	17.59
Tangible Book Value, 3 Yr. CAGR %	14.86	2.62	0.75	2.14	17.98
Cash From Operations, 3 Yr. CAGR %	24.75	7.16	8.49	9.76	10.03
Capital Expenditures, 3 Yr. CAGR %	-34.57	-35.41	-17.65	-10.68	-0.22
Levered Free Cash Flow, 3 Yr. CAGR %	-12.05	-11.54	-42.86	284.43	91.6
Unlevered Free Cash Flow, 3 Yr. CAGR %	-58.86	-14.39	-44.84	283.99	91.92
Dividend Per Share, 3 Yr. CAGR %	59.56	-12.44	-12.42	0	20.44
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	10.95	6.62	7.21	-14.52	-14.69
Gross Profit, 5 Yr. CAGR %	11.64	-0.11	3.43	2.13	11.71
EBITDA, 5 Yr. CAGR %	13.72	-13.75	0.77	9.8	22.26
EBITA, 5 Yr. CAGR %	13.74	-15.45	-0.04	9.85	22.82
EBIT, 5 Yr. CAGR %	13.78	-15.63	-0.12	9.87	22.89
Earnings From Cont. Operations, 5 Yr. CAGR %	21.76	0.46	13.65	13.04	24.96
Net Income, 5 Yr. CAGR %	21.63	-0.11	13.12	12.9	25.11
Normalized Net Income, 5 Yr. CAGR %	15.76	-11.86	-6.14	14.08	27.84
Diluted EPS Before Extra, 5 Yr. CAGR %	22.22	0.13	13.9	13.04	25.22
Net Property, Plant and Equip., 5 Yr. CAGR %	13.43	5.84	3.34	0.36	-0.15
Accounts Receivable, 5 Yr. CAGR %	8.69	6.88	6.58	-	-
Total Assets, 5 Yr. CAGR %	12.64	12.63	12.59	12.68	12.29
Common Equity, 5 Yr. CAGR %	9.53	6.33	7.64	4.77	5.75
Tangible Book Value, 5 Yr. CAGR %	9.58	6.34	7.8	4.85	5.86
Cash From Operations, 5 Yr. CAGR %	26.31	11.86	21.35	5.78	8.63
Capital Expenditures, 5 Yr. CAGR %	0.61	-20.39	-26.58	-19	-16.37
Levered Free Cash Flow, 5 Yr. CAGR %	-37.01	-0.77	-18.62	51.38	80.97
Unlevered Free Cash Flow, 5 Yr. CAGR %	-54.88	-3.24	-24.41	48.34	71.76
Dividend Per Share, 5 Yr. CAGR %	22.05	4.14	21.86	-2.29	5.99